UIVAX Mutual Fund

NAV$22.09

Fund Essentials - as of Jan 31, 2026

Net Assets
$617M
Expense Ratio
0.91%
Dividend Yield (Current)
10.09%
Holdings
182
Inception Date
Aug 1, 2008
Fund Family
Victory Capital Management Inc.
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+12.76%
1 Year+30.88%
3 Year+19.58%
5 Year+12.76%
10 Year+11.70%

Asset Allocation

Stocks: 99.77%
Cash: 0.11%
Other: 0.11%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
GOOGLAlphabet Inc Common Stock USD 0.0013.54%
JPMJpmorgan Chase2.40%
CCitigroup Inc.1.99%
JNJJohnson & Johnson1.94%
KEYKeycorp1.94%
Top 10 Concentration: 19.64%Report Date: Jan 31, 2026
Download all 182 holdings for UIVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.09%
Frequency
Annually
Latest Distribution
$0.26
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how UIVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

UIVAX Mutual Fund Overview

UIVAX Mutual Fund (Victory Value Fund Institutional Class) is managed by Victory Capital Management Inc. with $616.6M in net assets. UIVAX expense ratio is 0.91%, holding 182 positions across sectors including Financials, Information Technology, Health Care. Inception date: 2008-08-01.

UIVAX performance shows a YTD return of 12.76%. The 1-year return is 30.88% and the 5-year return is 12.76%. UIVAX dividend yield stands at 10.09%, paid annually.

UIVAX top holdings include Alphabet Inc Common Stock USD 0.001 (3.5%), Jpmorgan Chase (2.4%), Citigroup Inc. (2.0%), Johnson & Johnson (1.9%), Keycorp (1.9%). View all UIVAX holdings, sector breakdown, or dividend history.

UIVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. UIVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.